Buprenorphine-related deaths: Unusual forensic situations

International Journal of Legal Medicine

Volumn 124, Issue 6, 2010, Pages 647-651

  Pelissier Alicot, Anne Laure ^a   Sastre, Caroline ^a   Baillif Couniou, Valerie ^a   Gaulier, Jean Michel ^b   Kintz, Pascal ^c   Kuhlmann, Erika ^d   Perich, Pierre ^a   Bartoli, Christophe ^a   Piercecchi Marti, Marie Dominique ^a   Leonetti, Georges ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c Laboratoire ChemTox   (France)

^d Centre Universitaire des Saints Pères   (France)

Author keywords

Benzodiazepines; Death; High dose buprenorphine; Liver failure; Non substitutive use

Indexed keywords

BUPRENORPHINE; NARCOTIC ANALGESIC AGENT;

ACID ASPIRATION; ADDICTION; ADULT; ARTICLE; CASE REPORT; FATALITY; FEMALE; HUMAN; INTOXICATION; MALE; MIDDLE AGED; SUICIDE;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; OVERDOSE; RESPIRATORY ASPIRATION; SUBSTANCE-RELATED DISORDERS; SUICIDE;

EID: 78651239045     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-010-0449-1     Document Type: Article

References (26)

1. Rolly G, Versichelen L (1976) Buprenorphine as postoperative analgesic. Acta Anaesthesiol Belg 27:183-186
2. Adriaensen H, Van DeWalle J (1976) Clinical use of buprenorphine in chronic administration. Acta Anaesthesiol Belg 27:187-191
3. Auriacombe M, Fatseas M, Daulouede JP (2008) Therapeutiques de substitution aux opiacés: méthadone orale et buprénorphine sublinguale. In: Reynaud M (ed) Traité d'addictologie, 2nd edn. Medecine-Sciences Flammarion, Paris, pp 620-644
4. Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 55:569-580
5. Obradovic I, Canarelli T (2008) The initial prescription of methadone in health establishments. An analysis of medical practices in hospital and penal environments since the introduction of the circular dated January 30, 2002. Tendances 60:1-4
6. Kintz P (2001) Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int 121:65-69
7. Kintz P (2002) A new series of 13 buprenorphine-related deaths. Clin Biochem 35:513-516
8. Lai SH, Yao YJ, Lo DS (2006) A survey of buprenorphine related deaths in Singapore. Forensic Sci Int 162:80-86
9. Tracqui A, Kintz P, Ludes B (1998) Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J Anal Toxicol 22:430-434
10. Valenciano M, Emmanuelli J, Lert F (2001) Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction 96:597-606
11. Reynaud M, Petit G, Potard D, Courty P (1998) Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 93:1385-1392
12. Ministère de la Justice. Note SJ-06-240-AB3/04.08.06 relative à la tarification des analyses toxicologiques
13. Pirnay S, Borron SW, Giudicelli CP, Tourneau J, Baud FJ, Ricordel Y (2004) A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 99:978-988
14. Megarbane B, Deye N, Baud FJ (2004) Contribution of experimental data to respiratory depression induced by psychotropic drugs. Réanimation 13:334-342
15. Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T (1996) Kinetics of respiratory depression in rats induced by buprenorphine ans its metabolite, norbuprenorphine. J Pharmacol Exp Ther 281:428-433
16. Megarbane B, Hreiche R, Pirnay S, Marie N, Baud FJ (2006) Does high-dose buprenorphine cause respiratory depression? Possible mechanisms and therapeutic consequences. Toxicol Rev 25:79-85
17. Pirnay S, Megarbane B, Decleves X, Risede P, Borron SW, Bouchonnet S, Perrin B, Debray M, Milan N, Duarte T, Ricordel Y, Baud FJ (2008) Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats. Toxicol Sci 106:64-73
18. Robertson MD, Drummer OH (1998) Stability of nitrobenzodiazepines in postmortem blood. Forensic Sci 43:5-8
19. Iribarne C, Picard D, Dreano Y, Bail JP, Berthou F (1997) Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci 60:1953-1964
20. Kobayashi K, Yamamoto T, Chiba K, Tani M, Shimada N, Ishizaki T, Kuroiwa Y (1998) Human buprenorphine N-dealkylation is catalysed by cytochrome P450 3A4. Drug Metab Dispos 26:818-821
21. Tegeder I, Lötsch J, Geisslinger G (1999) Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 37:17-40
22. Peyriere H, Tatem L, Bories C, Pageaux GP, Blayac JP, Larrey D (2009) Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis. Ann Pharmacother 43:973-977
23. Zuin M, Giorgini A, Selmi C, Battezzati PM, Cocchi CA, Crosignani A, Benetti A, Invernizzi P, Podda M (2009) Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig Liver Dis 41:e8-e10
24. Kintz P, Villain M, Tracqui A, Cirimele V, Ludes B (2003) Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy. J Anal Toxicol 27:527-529
25. First MB, Tasman A (2004) DSM-IV-TRTM mental disorders. Diagnosis, etiology and treatment. Wiley, Chichester, pp 351-372
26. Escots S, Fahet G (2004) Usages non substitutifs de la buprenorphine haut dosage. Investigation menée en France en 2002-2003. Observatoire Français des Drogues et des Toxicomanies. http://www.ofdt.fr/BDD/ publications/docs/epfxsek6.pdf